Engineered Plant-Derived Nanovesicles Facilitate Tumor Therapy: Natural Bioactivity Plus Drug Controlled Release Platform
Xiaohang Chen,Shuaiqi Ji,Yuxiang Yan,Shuoqi Lin,Lianghang He,Xiaoyu Huang,Lin Chang,Dali Zheng,Youguang Lu
DOI: https://doi.org/10.2147/IJN.S413831
IF: 7.033
2023-08-22
International Journal of Nanomedicine
Abstract:Xiaohang Chen, 1, 2 Shuaiqi Ji, 1, 2 Yuxiang Yan, 1 Shuoqi Lin, 1, 2 Lianghang He, 1, 2 Xiaoyu Huang, 2 Lin Chang, 2 Dali Zheng, 1 Youguang Lu 1, 2 1 Fujian Key Laboratory of Oral Diseases, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, People's Republic of China; 2 Department of Preventive Dentistry, School and Hospital of Stomatology, Fujian Medical University, Fuzhou, People's Republic of China Correspondence: Youguang Lu; Dali Zheng, Email ; Tumors are the second-most common disease in the world, killing people at an alarming rate. As issues with drug resistance, lack of targeting, and severe side effects are revealed, there is a growing demand for precision-targeted drug delivery systems. Plant-derived nanovesicles (PDNVs), which arecomposed of proteins, lipids, RNA, and metabolites, are widely distributed and readily accessible. The potential for anti-proliferative, pro-apoptotic, and drug-resistant-reversing effects on tumor cells, as well as the ability to alter the tumor microenvironment (TME) by modulating tumor-specific immune cells, make PDNVs promising anti-tumor therapeutics. With a lipid bilayer structure that allows drug loading and a transmembrane capacity readily endocytosed by cells, PDNVs are also expected to become a new drug delivery platform. Exogenous modifications of PDNVs enhance their circulating stability, tumor targeting ability, high cell endocytosis rate, and controlled-release capacity. In this review, we summarize PDNVs' natural antitumor activity, as well as engineered PDNVs as efficient precision-targeted drug delivery tools that enhance therapeutic effects. Additionally, we discuss critical considerations related to the issues raised in this area, which will encourage researchers to improve PDNVs as better anti-tumor therapeutics for clinic applications. Graphical Keywords: plant-derived nanovesicles, cancer therapy, natural bioactivity, drug delivery platform, engineered EVs, targeted precision therapy Graphical Tumors are the second leading cause of death worldwide, with approximately 1670 deaths per day in the United States and 7700 deaths per day in China. 1,2 The fundamental reason why cancers are still considered "frightening" is the difficulty of early tumor detection and the variety of issues present in tumor treatments, including but not limited to the following: (1) Surgical resection is the primary form of treatment, but it is unable to remove the tiny potential unlocated tumor foci that may become a fatal hidden danger. In addition, some tumors that are detected may be missed by surgical indicator, and thus require combination with radiotherapy and other means for removal. 3,4 (2) Chemotherapeutic drugs lack targeting and enter the body with the blindness of "one thousand killed, eight hundred lost", resulting in severe side effects such as lowered immunity and other issues. 5 (3) Although emerging immunotherapy has been proven to be effective for some tumors, many "cold tumors" are 'insensitive' to immunotherapy. 6 (4) Following drug therapy, the mutating tumor cells will progressively develop drug resistance ability, resulting in drug treatment failure. 7 Accordingly, there is a growing demand for more efficient targeted tumor treatment, particularly in precision-targeted drug delivery systems. 8,9 The field of targeted tumor therapy has seen many exciting advancements in the precision drug delivery system, particularly in the area of nanomaterials. 10 (1) Through surface functionalization, nanomaterials can possess highly precise targeting delivery capabilities; 11 (2) Encapsulation by nanomaterials can protect drugs from degradation and clearance in vivo, enhancing drug stability and bioavailability; 12 (3) Nanomaterials can enhance penetration and retention efficiency, further improving drug penetration efficiency and specificity; 13 (4) Regulating the structure and composition of nanomaterials can achieve efficient drug release, among other benefits. 14 As a novel emerging drug delivery tool, exosomes derived from animals possess advantages including natural origin, good biocompatibility, natural targeting ability, and biodegradability. 15 However, they currently face challenges such as low yield and high costs. 16 Therefore, PDNVs, also known as plant derived exosomes like nanoparticles, have become an alternative option, as they offer similar advantages and are easier to produce at a lower cost. 17 PDNVs are extensively distributed in a range of plants and function as cellular messenge -Abstract Truncated-
pharmacology & pharmacy,nanoscience & nanotechnology